[{"NetIncomeLoss_1_Q3_USD":-33818000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":96644000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":834000.0,"AssetsCurrent_0_Q3_USD":209914000.0,"OperatingLeaseExpense_3_Q3_USD":414000.0,"OperatingLeaseExpense_1_Q3_USD":138000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":33006000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":11289000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":2692000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":null,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":5275914.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":818000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":238000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-392000.0,"CommonStockSharesIssued_0_Q3_shares":44204745.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":134114000.0,"Assets_0_Q3_USD":215477000.0,"ShareBasedCompensation_3_Q3_USD":13198000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1871000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":238000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":53398000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ResearchAndDevelopmentExpense_3_Q3_USD":68496000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":22995000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":4006000.0,"AssetsFairValueDisclosure_0_Q3_USD":134114000.0,"ProceedsFromStockPlans_3_Q3_USD":522000.0,"CommonStockValue_0_Q3_USD":44000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-8387000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":512000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1589000.0,"RestrictedCash_0_Q3_USD":403000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":201784000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-98861000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-34210000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":67670000.0,"Liabilities_0_Q3_USD":18540000.0,"OperatingLeaseLiability_0_Q3_USD":3211000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":44097178.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":44142334.0,"AccruedLiabilitiesCurrent_0_Q3_USD":11536000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":199000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":795000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1092000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-392000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-92857000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":802000.0,"LiabilitiesCurrent_0_Q3_USD":15848000.0,"AccountsPayableCurrent_0_Q3_USD":3793000.0,"NonoperatingIncomeExpense_3_Q3_USD":2403000.0,"NonoperatingIncomeExpense_1_Q3_USD":466000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":68073000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8130000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1067000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":131000.0,"AdditionalPaidInCapital_0_Q3_USD":621085000.0,"OperatingLeasePaymentsUse_3_Q3_USD":587000.0,"LesseeOperatingLeaseDiscountRate_0_Q3_pure":0.1,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":198000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":3289000.0,"NetIncomeLoss_3_Q3_USD":-99099000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4695000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":851000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":238000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":5376000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"OperatingIncomeLoss_3_Q3_USD":-101502000.0,"OperatingIncomeLoss_1_Q3_USD":-34284000.0,"InvestmentIncomeInterest_3_Q3_USD":2403000.0,"InvestmentIncomeInterest_1_Q3_USD":466000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":215477000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":519000.0,"OperatingExpenses_3_Q3_USD":101502000.0,"OperatingExpenses_1_Q3_USD":34284000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.25,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.77,"ProfitLoss_3_Q3_USD":-99099000.0,"ProfitLoss_1_Q3_USD":-33818000.0,"StockholdersEquity_0_Q3_USD":196937000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":130000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":133876000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":150172000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-424430000.0,"CommonStockSharesOutstanding_0_Q3_shares":44204745.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1085000.0,"Ticker":"RYTM","CIK":"1649904","name":"RHYTHM PHARMACEUTICALS, INC.","OfficialName":"Rhythm Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"415723429.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201102"}]